These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3017590)

  • 1. [Determination of the virus content in oral trivalent candy poliovaccine using monoclonal antibodies to poliovirus].
    Chen SF; Jiang SD; Guan ZD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Feb; 8(1):72-3. PubMed ID: 3017590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of two schedules for administering trivalent oral poliovaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):275-7. PubMed ID: 3004841
    [No Abstract]   [Full Text] [Related]  

  • 3. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
    Sawyer LA; Wood D; Ferguson M; Crainic R; Beuvery EC; McInnis J; Albrecht P
    Biologicals; 1997 Sep; 25(3):299-306. PubMed ID: 9324998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on immunization of polio vaccine. II. Comparison of responses obtained by different forms of polio vaccine].
    Su W
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):284-5. PubMed ID: 1664296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic analysis of 100 strains of poliomyelitis type I virus by monoclonal antibody].
    Gu FZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):265-7. PubMed ID: 3004840
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.
    Benyesh-Melnick M; Melnick JL; Rawls WE; Wimberly I; Oro JB; Ben-Porath E; Rennick V
    Am J Epidemiol; 1967 Jul; 86(1):112-36. PubMed ID: 4378110
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of antibodies in a population immunized with oral poliovaccine (OPV).
    Srámová H; Teplý V; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):212-9. PubMed ID: 231625
    [No Abstract]   [Full Text] [Related]  

  • 10. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thermostability and immunogenicity of trivalent oral poliovirus vaccine produced by different countries].
    Kong J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):151-4. PubMed ID: 8221837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of allogenic hybridomas for production of monoclonal antibodies against oral polio vaccine strains.
    Gupta CK; Sokhey J; Gupta RK; Singh H
    Vaccine; 1991 Nov; 9(11):853-4. PubMed ID: 1661979
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies.
    Horie H; Sato-Miyazawa M; Ota Y; Wakabayashi K; Doi T; Yoshizawa K; Doi Y; Hashizume S
    Biologicals; 1999 Sep; 27(3):217-26. PubMed ID: 10652177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain differentiation of polioviruses with monoclonal antibodies.
    Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
    Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.
    Osei-Kwasi M; Afari EA; Mimura K; Obeng-Ansah I; Ampofo WK; Nkrumah FK
    Bull World Health Organ; 1995; 73(1):41-6. PubMed ID: 7704924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
    Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
    Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mathematical insight to poliovaccine failures.
    Arya SC
    Indian J Pathol Microbiol; 1985 Apr; 28(2):177-8. PubMed ID: 3011661
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
    Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
    Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When can we stop using oral poliovirus vaccine?
    Hull HF; Minor PD
    J Infect Dis; 2005 Dec; 192(12):2033-5. PubMed ID: 16288363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.